Nathaniel Calloway

Director, Anebulo Pharmaceuticals, Inc.

Companies

Anebulo Pharmaceuticals, Inc.Board member Nov 2, 2022 to Apr 7, 2025¹
LIFECORE BIOMEDICAL, INC. \DE\Board member Jan 11, 2023 to Jul 10, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

LIFECORE BIOMEDICAL, INC. \DE\ LFCR58,069 shares³$374.0K at $6.44Jul 8, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 8, 2024Granted 30,000 shares of LIFECORE BIOMEDICAL, INC. \DE\³
Feb 1, 2024Exercised options 3,981 shares of LIFECORE BIOMEDICAL, INC. \DE\⁴
Jan 9, 2024Exercised options 5,906 shares of LIFECORE BIOMEDICAL, INC. \DE\⁵
Jun 1, 2023Granted 18,182 shares of LIFECORE BIOMEDICAL, INC. \DE\⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAnebulo Pharmaceuticals, Inc., Board member
2
SEC EDGARLIFECORE BIOMEDICAL, INC. \DE\, Board member
3
SEC EDGARLIFECORE BIOMEDICAL, INC. \DE\ shares after the filing of Jul 8, 2024
4
SEC EDGARForm 4 filed Feb 2, 2024
5
SEC EDGARForm 4 filed Jan 10, 2024
6
SEC EDGARForm 4 filed Jun 5, 2023